TEVA Phamaceuticals Recalls Single Lot of Metoprolol Tartrate Tablets 50 mg

TEVA Phamaceuticals Recalls Single Lot of Metoprolol Tartrate Tablets 50 mg

TEVA Phamaceuticals has recalled a single lot of Metoprolol Tartrate Tablets 50 mg, the short acting formulation of metoprolol. Lot number TE1Y261 is being recalled because some tablets in this lot may have different thickness and weight.

Metoprolol is used in the treatment of high blood pressure. Metoprolol is also sold under the brand name Lopressor or Toprol XL. No other lots, strengths, or brands of Metoprolol were involved in this recall.

To view the FDA notice about this recall, please visit:
http://www.mediguard.org/r/013V22sm0gzA

****
WHAT DOES THIS MEAN? 

 

This recall for Metoprolol Tartrate Tablets 50 mg from TEVA Phamaceuticals was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Metoprolol Tartrate Tablets 50 mg from Teva Pharmaceuitcals and are concerned, you should speak to your pharmacist or doctor. If you think you are experiencing side effects from your medicine, please follow up with your doctor.

For updated risk ratings on all of your registered medications, or to update your medication list, please log into your profile (https://www.mediguard.org/user). 

 

You can also reach your profile by clicking on the link in the top right corner of any page on our web site.

**** PLEASE TELL YOUR FRIENDS

We want to continually improve our service, and hope you want to help us too.

Please reply with any suggestions, ideas, comments or feedback that we can use to make our service more valuable for you.

Do you know anyone who could benefit from the MediGuard service? Click the link below to refer MediGuard to your family and friends:

http://www.mediguard.org/referral

---

DISCLAIMER
MediGuard is not intended to be a substitute for professional medical advice. MediGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the MediGuard site and its content is at your own risk. (c) 2011 iGuard, Inc.. All rights reserved. iGuard, Inc., 66 Witherspoon St #262, Princeton, NJ 08542.
For more information about MediGuard, please visit: http://www.mediguard.org

---

We hope you found this message to be useful. However, if you'd rather not receive future e-mails of this sort from MediGuard, please visit the unsubscribe link here:
https://www.mediguard.org/user/unsubscribe

NOTE: Some AOL users and others may need to copy-and-paste the link into their browser's address bar.